Bioactive peptides and metabolic health: a mechanistic review of the impact on insulin sensitivity, lipid profiles, and inflammation

Mamoudou Hamadou
{"title":"Bioactive peptides and metabolic health: a mechanistic review of the impact on insulin sensitivity, lipid profiles, and inflammation","authors":"Mamoudou Hamadou","doi":"10.1016/j.afres.2025.101056","DOIUrl":null,"url":null,"abstract":"<div><div>Bioactive peptides, derived from dietary proteins including dairy, legumes, and marine sources, demonstrate various regulatory effects on metabolic homeostasis via specific biochemical interactions. These peptides improve insulin sensitivity by activating the IRS-1/PI3K/Akt pathway and facilitating AMPK-mediated GLUT4 translocation, while also influencing incretin hormones through CaSR-dependent GLP-1 secretion, DPP-4 inhibition, and digestive enzymes (α-amylase and α-glucosidase) inhibition. Their influence encompasses lipid metabolism, characterized by the suppression of cholesterol synthesis through HMG-CoA reductase downregulation and the promotion of fatty acid oxidation via PPARα/AMPK signaling. In addition to glucoregulation, bioactive peptides demonstrate significant anti-inflammatory and antioxidant effects through the inhibition of NF-κB/MAPK pathways, the scavenging of reactive oxygen species (ROS), and the activation of Nrf2-driven cytoprotective genes. They regulate adipokine signaling, including leptin sensitization and adiponectin secretion, as well as cardiometabolic hormones, such as angiotensin-converting enzyme inhibition and cortisol reduction. These mechanisms result in enhanced glycemic control, diminished adipose tissue dysfunction, and lowered cardiovascular risk. Bioactive peptides have shown efficacy in preclinical models and are promising nutraceutical candidates for the management of metabolic disorders such as type 2 diabetes, obesity, and atherosclerosis. Translational challenges, including oral bioavailability and dose optimization, require additional investigation to fully realize their therapeutic potential. Bioactive peptides play a significant role in metabolic regulation, particularly in enhancing insulin sensitivity. These compounds are increasingly recognized as nutraceuticals due to their potential effects on inflammation and hormone modulation.</div></div>","PeriodicalId":8168,"journal":{"name":"Applied Food Research","volume":"5 2","pages":"Article 101056"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Applied Food Research","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772502225003646","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Bioactive peptides, derived from dietary proteins including dairy, legumes, and marine sources, demonstrate various regulatory effects on metabolic homeostasis via specific biochemical interactions. These peptides improve insulin sensitivity by activating the IRS-1/PI3K/Akt pathway and facilitating AMPK-mediated GLUT4 translocation, while also influencing incretin hormones through CaSR-dependent GLP-1 secretion, DPP-4 inhibition, and digestive enzymes (α-amylase and α-glucosidase) inhibition. Their influence encompasses lipid metabolism, characterized by the suppression of cholesterol synthesis through HMG-CoA reductase downregulation and the promotion of fatty acid oxidation via PPARα/AMPK signaling. In addition to glucoregulation, bioactive peptides demonstrate significant anti-inflammatory and antioxidant effects through the inhibition of NF-κB/MAPK pathways, the scavenging of reactive oxygen species (ROS), and the activation of Nrf2-driven cytoprotective genes. They regulate adipokine signaling, including leptin sensitization and adiponectin secretion, as well as cardiometabolic hormones, such as angiotensin-converting enzyme inhibition and cortisol reduction. These mechanisms result in enhanced glycemic control, diminished adipose tissue dysfunction, and lowered cardiovascular risk. Bioactive peptides have shown efficacy in preclinical models and are promising nutraceutical candidates for the management of metabolic disorders such as type 2 diabetes, obesity, and atherosclerosis. Translational challenges, including oral bioavailability and dose optimization, require additional investigation to fully realize their therapeutic potential. Bioactive peptides play a significant role in metabolic regulation, particularly in enhancing insulin sensitivity. These compounds are increasingly recognized as nutraceuticals due to their potential effects on inflammation and hormone modulation.

Abstract Image

生物活性肽与代谢健康:对胰岛素敏感性、脂质谱和炎症影响的机制综述
生物活性肽来源于膳食蛋白质,包括乳制品、豆类和海洋来源,通过特定的生化相互作用对代谢稳态表现出各种调节作用。这些肽通过激活IRS-1/PI3K/Akt通路和促进ampk介导的GLUT4易位来改善胰岛素敏感性,同时还通过casr依赖性GLP-1分泌、DPP-4抑制和消化酶(α-淀粉酶和α-葡萄糖苷酶)抑制来影响肠促胰岛素激素。它们的影响包括脂质代谢,其特征是通过下调HMG-CoA还原酶抑制胆固醇合成,并通过PPARα/AMPK信号传导促进脂肪酸氧化。除了调节血糖外,生物活性肽还通过抑制NF-κB/MAPK通路、清除活性氧(ROS)和激活nrf2驱动的细胞保护基因,显示出显著的抗炎和抗氧化作用。它们调节脂肪因子信号,包括瘦素致敏和脂联素分泌,以及心脏代谢激素,如血管紧张素转换酶抑制和皮质醇减少。这些机制可以增强血糖控制,减少脂肪组织功能障碍,降低心血管风险。生物活性肽在临床前模型中显示出疗效,是治疗代谢性疾病(如2型糖尿病、肥胖和动脉粥样硬化)的有希望的营养候选药物。转化方面的挑战,包括口服生物利用度和剂量优化,需要进一步研究以充分发挥其治疗潜力。生物活性肽在代谢调节中发挥重要作用,特别是在提高胰岛素敏感性方面。由于这些化合物对炎症和激素调节的潜在影响,它们越来越被认为是营养保健品。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.50
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信